ArticleClinical and experimental medicine2017

Low-dose gemcitabine induces major histocompatibility complex class I-related chain A/B expression and enhances an antitumor innate immune response in pancreatic cancer.

Tomoharu Miyashita et al.PubMed ↗Publisher ↗

No numbers read from the abstract.